FDA Donor Screen: Test Panels & Directory
An ART cycle which uses more than one ART procedure. Combination cycles usually combine IVF with either GIFT or ZIFT.
THE SCFA assesses the physical structure of sperm DNA. If there is too much damage (also known as DNA breaks) to key parts of the DNA message, then it may be rendered either partially or completely unreadable (and the pregnancy may terminate prematurely or not occur at all).
CPT: 86703
Specimen: Serum
Collection: Tiger SST
Shipping: Ambient
Stability: Refrigerated – 7 days; Frozen – Longer than 7 days
Method: Enzyme-Linked Immunosorbent Assay
Approved by FDA for Donor Screening License #1109
Antithyroglobulin Antibodies (ATA) can cause problems with the function of your thyroid. These antibodies can disrupt other hormone levels, thus affecting egg production. Treatment for high ATA levels may consist of steroids.
Antisperm Antibodies (ASA) can be found in both males and females. Males who have had vasectomy reversal or have injured their testicles can produce ASA (semen specimen) Female (blood test) ASA are found in the cervical mucus as well as in blood. The ASA attaches to the head of the sperm and make it hard for the sperm to penetrate an egg. IVF with ICSI treatment is recommended for couples with ASA.
The Anti Phospholipids Antibody (APA) test is conducted if you have had multiple miscarriages. APA can interfere with the embryo implanting. APA disrupts the normal clotting of blood and the adhesion of the embryo to the uterus. APA tests for a number of different antibodies. If your test results show that two or more are positive treatment is either by baby aspirin or heparin.
Antinuclear Antibodies (ANA) can increase your risk of miscarriage when the result is a low positive with a speckled pattern. If your result highly positive you may have a disease called systemic lupus erythematosus (SLE). A positive ANA level may be treated with low-dose steroids.
Antiovarian Antibodies (AOA). This test is ordered when early menopause or premature ovarian failure are possible diagnoses.
Natural killer (NK) cells of white blood cells that attack and destroy anything that is a foreign substance in the body. If the NK cell count is high these cells may be aggressive and attack a growing embryo. Treatment for NK cells is intravenous immunoglobulin therapy (IVIG). This can be very expensive procedure and controversial among infertility specialists. A drug called Enbrel can also be used to treat NK cells.
No, not necessarily. Although evidence shows that Zika virus infection during pregnancy is a cause of birth defects and other poor pregnancy outcomes, not all Zika virus infections result in these problems. At this time, we do not know how likely it is that a baby will have microcephaly or other problems if his/her mother is infected with Zika virus while she is pregnant.
A positive test result for Zika virus infection during pregnancy signals to your healthcare providers to watch your pregnancy more closely, meaning they might do more ultrasounds or other tests to check the growth and development of your fetus.
CPT: 80307
Specimen: Urine Collection: Urine Cup Shipping: Ambient Stability: Refrigerated – 2 days; Frozen – Longer than 2 days Method: Chromatographic immunoassay
There are treatments available for women with PCOS. These treatments do not cure the disease but rather help improve the symptoms of PCOS. For women with PCOS who are obese, diet and exercise to maintain a normal body weight may alleviate many of the symptoms of PCOS. In fact, for obese women, losing even 5-10% of body weight may help. Oral contraceptive pills are often given to correct some of the hormonal imbalances found in PCOS and can help decrease acne and excess hair growth as well as regulate menstrual cycles. Acne can also be treated with topical ointments or antibiotic creams. Women with excess hair growth often find laser electrolysis helpful. Metformin is an oral medication that may be prescribed to women with PCOS who are insulin resistant. Women who are having difficulties conceiving may take a medication called clomiphene citrate or clomid to help them ovulate regularly. In women with PCOS who take clomid, about 80% will ovulate in response to the medication and 30-40% will become pregnant. About half of women will ovulate when taking one pill a day (50 mg) on cycle days five through nine. The other 50% of women do not ovulate on this dose of clomid and may need a higher dose or another medication. Using clomid increases your chances of having a multiple pregnancy to 8-13%, with twins being the most common. If pregnancy does not occur after six cycles of clomid use, further evaluation or a change in therapy is recommended. If you think you may be experiencing any or all of the symptoms of PCOS, it is important to see a doctor for diagnosis and treatment.
Pregnant women who have recently traveled to an area with risk of Zika should talk to their doctor about their travel, even if they don't feel sick. Pregnant women should see a doctor if they have any Zika symptoms during their trip or after traveling. All pregnant women can protect themselves by avoiding travel to an area with risk of Zika, preventing mosquito bites, and following recommended precautions against getting Zika through sex.
CPT: 86703
Specimen: Serum
Collection: Tiger SST
Shipping: Ambient
Stability: Refrigerated – 7 days; Frozen – Longer than 7 days
Method: Enzyme-Linked Immunosorbent Assay
Approved by FDA for Donor Screening License #1109
If you have a positive test result for “other flavivirus,” it is likely you have a dengue virus infection or a West Nile virus infection. If your result from this test is positive for other flavivirus, additional testing may be required and your health care provider or health department will work with you to help you understand the steps you should take to care for yourself.
CPT: 86703
Specimen: Serum
Collection: Tiger SST
Shipping: Ambient
Stability: Refrigerated – 7 days; Frozen – Longer than 7 days
Method: Enzyme-Linked Immunosorbent Assay
Approved by FDA for Donor Screening License #1109
CPT: 81220
Specimen: Whole Blood Collection: Lavender (EDTA) Shipping: Ambient Stability: Refrigerated – 2 weeks; Frozen – 1 month Method: PCR
CPT: 86592
Specimen: Serum
Collection: Tiger SST
Shipping: Ambient
Stability: Refrigerated – 7 days; Frozen – Longer than 7 days
Method: Flocculation
Cleared by FDA for Donor Screening
By use of the complete panel, ~40% of all fertility clinic patients with male factor issues will be identified; patients who can be directed to the appropriate Assisted Reproductive Technology (ART) early on in their treatment avoiding ART that won’t work.
Your scores from the SDD and SDAD Tests, and the SCFA will provide information to your physician that will be used to individualize your patient care, directing you to the treatment options best for you!
Knowing more about both male and female factors that may be negatively affecting your fertility will help minimize the time, and emotional and financial cost for you to bring home a baby!
We are learning that some male factor issues are potentially reversible and/or treatable!
There are many factors that can contribute to male infertility. Some of these problems can be structural abnormalities, sperm production disorders, ejaculatory disturbances and immunologic disorders. Perhaps it is best to break them out into 2 categories: Productive Factors and Obstructive Factors. In some cases of male infertility, the production of sperm is impacted whereas in obstructive issues cause problems with transporting the sperm to the semen.
Here’s a breakdown of the many different types of male factor problems that can pose an issue to conceiving:
Structural abnormalities
It is possible that there can be an abnormalities of the reproductive tract, leading to potential obstructions that partially or totally block the flow of sperm and/or seminal fluid. Some of these abnormalities may be present at birth (congenital), others may have occurred after infection of the urogenital tract, whereas others may have resulted from previous surgery.
Congenital defects
Sperm production disorders
This occurs when the production of the sperm is inhibited.
Vasectomy
Varicocele
Sperm production problems
Ejaculatory disorders
These prevent sperm from reaching the female.
Retrograde Ejaculation
Impotence
Immunologic disorders
Immunological disorders can prevent sperm from meeting and successfully penetrating the egg in the female genital tract.
Endocrine disorders
Antisperm antibodies
CPT: 86592
Specimen: Serum
Collection: Tiger SST
Shipping: Ambient
Stability: Refrigerated – 7 days; Frozen – Longer than 7 days
Method: Flocculation
Cleared by FDA for Donor Screening
A measurement of the sperm that can readily swim to fertilize the egg. According to the World Health Organization (WHO), there should be a minimum of 10 million motile sperm per milliliter of semen.
Currently, there is no evidence that a woman who has recovered from Zika virus infection (the virus has cleared her body) will have Zika-related pregnancy complications in the future. Based on information about similar infections, once a person has been infected with Zika virus and has cleared the virus from his or her body, he or she is likely to be protected from future Zika infections.
If you’re thinking about having a baby in the near future and you or your partner live in or traveled to an area with risk of Zika, talk with your doctor or other healthcare provider. See Women & Their Partners Trying to Become Pregnant.
CPT: 86592
Specimen: Serum
Collection: Tiger SST
Shipping: Ambient
Stability: Refrigerated – 7 days; Frozen – Longer than 7 days
Method: Flocculation
Cleared by FDA for Donor Screening
Body Weight:
Obesity is associated with infertility and a lower pregnancy rate in women undergoing in vitro fertilization (IVF). Women with a very low body mass index (BMI) also are more likely to experience infertility and have a lower likelihood of success with IVF than women whose BMI falls in the normal range. In men, obesity is also associated with infertility — sperm count and motility have been shown to be lower in obese men. Weight loss has been shown to improve semen parameters. Erectile dysfunction is more common in obese men. There is no scientific data that supports one diet over another with respect to maximizing fertility.
Exercise:
Some data that suggest that moderate exercise, regardless of BMI, is associated with the highest pregnancy rates in women. Daily exercise, however, has been shown to be associated with reduced fertility—especially if the excessive exercise results in menstrual irregularity. Exercise has a similar effect on men—one hour of exercise three times weekly seems to be associated with a higher count, motility, and normal appearing sperm than sperm from men who do not exercise and those who engaged in more frequent/vigorous exercise
Caffeine Intake:
Excessive caffeine intake (>500 mg/day) appears to be associated with a delay in time to conception. Consumption of moderate amounts of caffeine (200-300 mg/day) has been associated with lower pregnancy rates and higher rates of miscarriage. In one study, pregnancy rates with IVF were reduced in women consuming greater than 50 mg of caffeine daily. There is little data on the impact of caffeine on male fertility. The average 8oz cup of coffee has approximately 100 mg of caffeine, but not all coffees are created equal—look up the caffeine content of your favorite caffeinated beverage.
Alcohol Consumption:
Extreme alcohol intake has been associated with decreased fertility. What is less clear is the amount of alcohol it takes to negatively impact reproductive function. A review of the literature suggested that four drinks per week is associated with a decreased likelihood of successful IVF in women. Heavy alcohol consumption in men is associated with decreased sperm count, motility, and percent of normal appearing sperm. Some studies have shown a negative impact on sperm with more moderate drinking. Semen parameters have been shown to improve after three months of abstinence from alcohol.
Smoking:
There is strong evidence that nicotine negatively effects fertility. It has been suggested that women who smoke add ten years to their reproductive ages—a 30 year old smoker has the reproductive potential of a 40 year old! Smoking in men negatively impacts sperm quantity and quality and is associated with reduced success with IVF and intra-cytoplasmic sperm injection (ICSI). There is little scientific data on the impact of electronic cigarettes on fertility, but they contain nicotine, so they are likely associated with a decrease in fertility. Ideally, nicotine patches and gum should be avoided.
Recreational Drugs:
Studies on the impact of recreational drugs on female fertility are few. Women who use marijuana appear to be more likely to experience infertility. In men, marijuana has been found to increase ejaculation problems and impotence as well as reduce sperm count and motility. Most negative effects from recreational drugs have been shown to be reversed by discontinuing their use.
Cell Phones:
In some animal studies evaluating the effect of the radio-frequency electromagnetic radiation (RF-EMR) of cell phones on reproductive function, a negative impact on the ovaries, uterus, and embryo has been identified. Sperm exposed to RF-EMF have decreased motility and are more likely to have an abnormal appearance. The use of cell phones may decrease sperm concentration and motility as well as normal appearance. The abnormalities seemed to be directly related to the amount of use. However, there is no evidence that use of cell phones by women or men is associated with infertility.
CPT: 87109
Specimen: Swab Collection: Mycoplasma/Ureaplasma Transport Media (UTM) Storage: Ambient Stability: Refrigerated – 48 hours; Frozen – 1 month Method: Culture
Men who have traveled to a place with a CDC Zika travel notice or a red area of Zika active transmission in the United States should wait at least 6 months after travel (or 6 months after symptoms started if they get sick) before trying to conceive with their partner. Women should wait at least 8 weeks after travel (or 8 weeks after symptoms started if they get sick) before trying to get pregnant.
The waiting period is longer for men because Zika stays in semen longer than in other body fluids. Travelers to areas with risk of Zika but no CDC Zika travel notice should talk to their healthcare provider. Travelers to yellow Zika cautionary areas can consider waiting these timeframes before trying to conceive. If either partner has symptoms of Zika or tests positive for Zika after travel, they should follow the suggested timeframes above before trying to get pregnant.
Even if you have a negative test, you may have been infected with Zika virus. If your sample was collected just after you became ill, it is possible that your body had not yet had enough time to make antibodies for the test to measure. If the sample was collected more than 12 weeks after your illness, it is possible that your body has already fought off the virus and the amount of antibodies is so low that they cannot be measured. Your healthcare provider will help you to interpret your test results and work with you to continue to monitor your health and, if you are pregnant, the health of your fetus.
CPT: 87516, 87521, 87535
Specimen: Plasma
Collection: Lavender (EDTA)
Shipping: Ambient
Stability: Ambient - 3 days; Refrigerated – 5 days
Method: Real time PCR
Approved by FDA Donor Screening License #1636
CPT: 87516, 87521, 87535
Specimen: Plasma
Collection: Lavender (EDTA)
Shipping: Ambient
Stability: Ambient - 3 days; Refrigerated – 5 days
Method: Real time PCR
Approved by FDA Donor Screening License #1636
The process of freezing extra embryos from a couple’s ART cycle for potential future use.
Inquiry into and removal from possible exposures to occupational and/or environmental reproductive toxicants, medications, alcohol, tobacco products and/or drugs of abuse (See Occupational Exposure Risks)
If you have an abnormal SDD Test score and a varicocele(s) identified by a urologist, recent unpublished data suggests you might benefit from a varicocelectomy.
Our most recent data shows that the daily use of Male Reproductive Supplements (MRS); anti-oxidant cocktails that include Vitamins C and E significantly improve abnormal SDAD Test scores.
It is very important you choose your ART wisely based on more than standard semen analysis where the typical treatment strategy is shown below!
CPT: 87516, 87521, 87535
Specimen: Plasma
Collection: Lavender (EDTA)
Shipping: Ambient
Stability: Ambient - 3 days; Refrigerated – 5 days
Method: Real time PCR
Approved by FDA Donor Screening License #1636
CPT: 87798
Specimen: Plasma
Collection: Lavender (EDTA)
Shipping: Ambient
Stability: Ambient - 3 days; Refrigerated – 5 days
Method: Real time PCR
Note: FDA recommends performing WNV testing on samples collected from June 1st through October 31st
Approved by FDA Donor Screening License #1636
The U.S. Food and Drug Administration (FDA) has not cleared or approved ZIKV Detect™ IgM Capture ELISA test or any other test to detect Zika virus infection. However, FDA has authorized the use of this test under an Emergency Use Authorization (EUA).
An EUA is a tool that FDA can use to allow the use of certain medical products for emergencies based on scientific data. The U.S. Secretary of Health and Human Services (HHS) has declared that circumstances exist to allow the emergency use of diagnostic tests for Zika virus infection, such as the ZIKV Detect™ IgM Capture ELISA, under an EUA.
FDA has authorized the emergency use of the ZIKV Detect™ IgM Capture ELISA to test for antibodies to Zika virus in your specimens only for the duration of the emergency, unless it is terminated or revoked by FDA sooner.
CPT: 87798
Specimen: Plasma
Collection: Lavender (EDTA)
Shipping: Ambient
Stability: Ambient - 3 days; Refrigerated – 5 days
Method: Real time PCR
Note: FDA recommends performing WNV testing on samples collected from June 1st through October 31st
Approved by FDA Donor Screening License #1636
CPT: 86794
Specimen: Serum Collection: Tiger SST Shipping: Ambient
Stability: Refrigerated – 2 days; Frozen - Longer than 2 days Method: EIA
A diagnosed condition which means the ability of the ovary to produce eggs is reduced. The reasons may either be congenital, medical, surgical causes or advanced maternal age (older than 40).
CPT: 87798
Specimen: Plasma
Collection: Lavender (EDTA)
Shipping: Ambient
Stability: Ambient - 3 days; Refrigerated – 5 days
Method: Real time PCR
Note: FDA recommends performing WNV testing on samples collected from June 1st through October 31st
Approved by FDA Donor Screening License #1636
Information about Zika virus is available at the CDC website.
Information about any significant new findings that are observed during the course of the emergency use of the ZIKV Detect™ IgM Capture ELISA will be made available at the InBios website.
CPT: 87662
Specimen: Plasma Collection: Lavender (EDTA) Shipping: Ambient
Stability: Refrigerated – 10 days; Frozen – Longer than 10 days Method: PCR
CPT: 86644
Specimen: Plasma
Collection: Lavender (EDTA)
Shipping: Ambient
Stability: Refrigerated – 10 days; Frozen – Longer than 10 days
Method: Solid phase red-cell adherence
Approved by FDA for Donor Screening
An embryo is formed from the donor egg of one woman (the donor) and then transferred to another woman who is unable to use her own eggs (the recipient). All parental rights are relinquished by the donor.
An embryo that is donated by a couple who previously underwent ART treatment and had extra embryos available. All parental rights are relinquished by the donor couple.
CPT: 86688
Specimen: Serum
Collection: Tiger SST
Shipping: Ambient
Stability: Refrigerated – 14 days; Frozen – Longer than 14 days
Method: Enzyme-Linked Immunosorbent Assay
Approved by FDA for Donor Screening License #1856
A pregnancy in which the fertilized egg implants in a location outside of the uterus, usually in the fallopian tube, the ovary, or the abdominal cavity.
A female reproductive cell, also called an oocyte or ovum.
A procedure to collect the eggs contained in the ovarian follicles.
The procedure of transferring retrieved eggs into a womans fallopian tubes through laparoscopy; this procedure is used only in GIFT.
An egg that has been fertilized by a sperm and undergone one or more divisions.
The procedure of placing an embryo into a womans uterus through the cervix after in vitro fertilization (IVF). During the process of zygote intrafallopian transfer (ZIFT), the embryos are placed in a womans fallopian tube.
A medical condition that involves the presence of tissue similar to the uterine lining in abnormal locations. This condition can affect both fertilization of the egg and embryo implantation.
The penetration of the egg by the sperm and the resulting combining of genetic material that develops into an embryo.
The unborn offspring from the eighth week after conception to the moment of birth.
A structure in the ovaries that contains a developing egg.
A hormone produced by the pituitary gland that helps an egg mature and be released. High levels of FSH indicate ovarian reserve is low and chances of conception are poor.
Eggs, sperm, or embryos that have not been frozen. However, fresh embryos may have been conceived using either fresh or frozen sperm.
An ART cycle in which frozen (cryopreserved) embryos are thawed and transferred to the woman.
A reproductive cell, either a sperm or an egg.
An ART procedure that involves removing eggs from the womans ovary, combining them with sperm, and using a laparoscope to place the unfertilized eggs and sperm into the womans fallopian tube through small incisions in her abdomen.
A woman who carries an embryo that was formed from the egg of another woman. The gestational carrier usually has a contractual obligation to return the infant to its intended parents.
A fluid-filled structure that develops within the uterus early in pregnancy. In a normal pregnancy, a gestational sac contains a developing fetus.
An ART procedure that involves removing eggs from a womans ovaries and fertilizing them outside her body. The resulting embryos are then transferred into the womans uterus through the cervix.
A surgical procedure in which a fiber optic instrument (a laparoscope) is inserted through a small incision in the abdomen to view the inside of the pelvis.
The delivery of one or more babies with any signs of life.
Any cause of infertility due to low sperm count or problems with sperm function that make it difficult for a sperm to fertilize an egg under normal conditions.
A pregnancy ending in the spontaneous loss of the embryo or fetus before 20 weeks of gestation.
This procedure is also known as selective reduction. A procedure used to decrease the number of fetuses a woman carries and improve the chances that the remaining fetuses will develop into healthy infants. Multi-fetal reductions that occur naturally are referred to as spontaneous reductions.
This diagnostic category means that more than one female infertility cause was diagnosed.
A diagnostic category used when one or more female/male infertility causes are diagnosed together.
A pregnancy that results in the birth of more than one infant.
A pregnancy with two or more fetuses, determined by the number of fetal hearts observed on an ultrasound performed early in pregnancy.
The female reproductive cell, also called an egg.
The use of ultrasound and/or blood or urine tests to monitor follicle development and hormone production.
Refers to a womans fertility potential in the absence of problems in her reproductive tract (fallopian tubes, uterus or vagina).
The use of medications to stimulate the ovaries to develop follicles and eggs.
A diagnostic category used when a womans ovaries are not producing eggs normally. It includes polycystic ovary syndrome (PCOS) and multiple ovarian cysts.
A pregnancy documented by ultrasound that shows a gestational sac in the uterus. For ART data collection purposes, pregnancy is defined as a clinical pregnancy rather than a chemical pregnancy (i.e., a positive pregnancy test).
The sperms ability to readily swim forward to fertilize the egg. Also referred to as sperm mobility.
Fetal death that occurs after 20 weeks gestation.
An ART cycle in which a woman receives oral or injected fertility drugs to stimulate her ovaries to produce more follicles.
Same as frozen embryo cycle.
A diagnostic category used when the womans fallopian tubes are blocked or damaged, making it difficult for the egg to be fertilized or for an embryo to travel to the uterus.
A technique used in ART for visualizing the follicles in the ovaries, the gestational sac, or the fetus.
An ART cycle in which the woman does not receive drugs to stimulate her ovaries to produce more follicles. Instead, follicles develop naturally.
A structural or functional disorder of the uterus that results in reduced fertility.
An ART procedure in which eggs are collected from a womans ovary and fertilized outside her body. A laparoscope is then used to place the resulting zygote (fertilized egg) into the womans fallopian tube through a small incision in her abdomen.
An AMH Test may be offered to any woman who has infertility or at high risk for infertility. Infertility is the failure to achieve pregnancy within 12 months of unprotected sex or donor insemination in woman who are younger than 35, or 6 months for women older than 35.
Because AMH remains stable during your menstrual cycle, it can be collected any time or day of the menstrual cycle. Fasting before blood collection is not required.
AMH testing is a simple way to measure your ovarian reserve. Ovarian reserve can predict your future response to ovarian stimulation. AMH results should be assessed in the context of a woman’s age.
Yes. Currently, AMH is one of the most accurate and reliable markers of ovarian reserve. However, data does not support testing for many diagnoses. The following is a list of such conditions.
· AMH testing should not be used as a fertility test for women who are not infertile or who have untested fertility.
· Routine AMH testing for prediction of pregnancy loss is not recommended.
· AMH testing is not useful in predicting the likelihood of unassisted pregnancy in women with infertility.
· AMH testing does not appear to predict pregnancy after OS/IUI for unexplained infertility.
· Extremely low levels of AMH should not be used to refuse treatment in IVF.
· AMH may only have a weak association with egg quality, pregnancy rates, and live birth rates.
· AMH levels may be decreased in women using hormonal birth control. Results should be interpreted with caution.
